左心发育不良综合征并非Fontan术后中期死亡率更差的预测因素
该研究纳入1996至2016年在阿尔伯塔大学接受Fontan手术的320例患儿,其中33.4%为左心发育不良综合征(HLHS)。HLHS并非院内Fontan失败、晚期再干预或无移植生存的预测因素,但HLHS患者晚期随访中更常见室功能异常和房室瓣反流。
要点
- HLHS不是Fontan术后院内失败、晚期再干预或无移植生存的预测因素。
- HLHS患者术前更常见室功能异常和超过轻度的房室瓣反流。
- HLHS患者晚期随访中室功能异常和房室瓣反流更常见。
核心结论
- 存活至Fontan手术的HLHS患者,其手术结局与其他解剖类型患者相当。
- 鉴于晚期室功能更差和房室瓣反流更多,同等生存可能不会贯穿患者一生。
研究设计与样本
- 回顾性队列研究,纳入1996至2016年阿尔伯塔大学所有接受Fontan手术的儿童患者,共320例,中位年龄3.3岁(IQR 2.8-3.9),121例(43.4%)女性。
主要发现
- HLHS患者107例(33.4%),术前室功能异常比例19.6% vs 7.0%(p=0.003),超过轻度房室瓣反流比例23.4% vs 9.2%(p=0.001)。
- HLHS对院内Fontan失败无预测作用(OR 0.82,95%CI 0.28-2.39),对晚期再干预无预测作用(HR 1.08,95%CI 0.66-1.76),对无移植生存无预测作用(HR 1.58,95%CI 0.72-3.44)。
- 晚期随访中,HLHS患者超过轻度房室瓣反流比例31.6% vs 13.3%(p=0.028),室功能异常比例29.8% vs 10.7%(p<0.0001)。
临床怎么用
- 对于存活至Fontan手术的HLHS患者,不应因解剖诊断而预期更差的院内或中期结局。
- 需加强HLHS患者Fontan术后的长期随访,重点关注室功能和房室瓣反流。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An increasing proportion of those living with single ventricle physiology have hypoplastic left heart syndrome (HLHS). Our objective was to assess the association between HLHS and outcomes post Fontan operation. METHODS: All pediatric patients who underwent a Fontan procedure at the University of Alberta between 1996 and 2016 were included. Follow-up clinical data collected included early and late surgical or catheter reintervention, echocardiography, and long-term transplant-free survival. Characteristics were compared between those with and without HLHS, and the association between outcomes and HLHS were assessed. RESULTS: A total of 320 children (median age 3.3 years, interquartile range 2.8 to 3.9 years; 121 [43.4%] female) underwent a Fontan procedure over the course of the study. Nearly one third of subjects had HLHS (107, 33.4%). Patients with HLHS were more likely to have abnormal ventricular function (19.6% versus 7.0%, p = 0.003) and worse than mild atrioventricular valve (AVV) regurgitation (23.4 versus 9.2%, p = 0.001) preoperatively. HLHS was not predictive of in-hospital Fontan failure (odds ratio 0.82, 95% CI 0.28, 2.39), late reintervention (hazard ratio [HR] 1.08, 95% CI 0.66, 1.76), or transplant-free survival (HR 1.58, 95% CI 0.72, 3.44). Subjects with HLHS were more likely to have more than mild AVV regurgitation (31.6% versus 13.3%, p = 0.028) and abnormal ventricular function (29.8% versus 10.7%, p < 0.0001) at late follow-up. CONCLUSIONS: Patients with HLHS who survive to the Fontan procedure do no worse with the operation than those with other anatomy. Given worse late ventricular function and AVV regurgitation, equivalent survival may not persist throughout a patient's life course.
引用
- Martin BJ, Mah K, Eckersley L, et al. Hypoplastic Left Heart Syndrome Is Not a Predictor of Worse Intermediate Mortality Post Fontan. Ann Thorac Surg. 2017. PMID: 29096870. doi:10.1016/j.athoracsur.2017.08.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。